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The first cases of community-associated methicillin-resistant 
Staphylococcus aureus (CA-MRSA) were reported in 1996 in 
Minnesota, United States (US) and were deep-seated skin and 
soft tissue infections and a few cases of necrotising pneumonia, 
mainly in children and among the Native American population 
[1]. A few years later, a large outbreak of CA-MRSA infections was 
reported in the men who have sex with men (MSM) community 
in California, predominantly among human immunodeficiency 
virus (HIV)-positive patients; data on sexual transmission was not 
available [2]. A recent report on the spread of CA-MRSA, mainly 
due to the widely disseminated strain “USA300”, in numerous 
MSM in San Francisco and in one patient in Boston suggested 
sexual transmission [3], but initiated critical reviews concerning the 
transmission route and the corresponding public health message 
[4,5]. 
CA-MRSA “USA300”, the most widely spread CA-MRSA strain 
in the US [6], has been detected in Germany since 2005 [7]. 
This clonal lineage is characterised by multilocus sequence type 
(MLST) ST8, spa-sequence type t008, SCCmec IVa, the presence 
of an additional arginine decomposition pathway (arginine catabolic 
mobile element (ACME) on a staphylococcal cassette chromosome 
(SCC)-element) with arcA as marker gene, and macrolide-resistance 
coded by the msrA (efflux pump) and mphB (phosphorylation) 
genes [7,8]. The contribution of ACME to virulence has been shown 
in a rabbit model [9]. The capacity of CA-MRSA “USA300” to 
cause invasive infections seems not to be due to production of the 
Panton-Valentine leukocidin cytotoxin, but rather to the synthesis 
of a large number of small phenol-soluble peptides, which are able 
to recruit and lyse neutrophilic granulocytes [10]. 
Here we report a case of infection with CA-MRSA ST8 
(“USA300”) in an HIV-positive 35-year-old MSM patient in 
Cologne, Germany. The isolate originated from an infected cyst 
in the upper abdominal area, which opened spontaneously. The 
patient suffered from acquired immunodeficiency syndrome (AIDS). 
His CD4+ T-cell count was 200/microlitre with a fully suppressed 
virus load due to HIV treatment. A specimen from the cyst was 
taken for microbiological diagnostics. Primary topical treatment 
was performed by instillation of Leukase beads containing trypsin, 
framycetin sulphate and lidocaine hydrochloride (Merck, Vienna). 
After obtaining the microbiology results, oral doxycyclin (200 mg 
per day) was included in the treatment. The infection had healed 
completely after 14 days. Nasal swabs were negative for MRSA. 
The isolate exhibited the typical characteristics of CA-MRSA ST8 
(“USA300”, see above). It was resistant to oxacillin, erythromycin, 
ciprofloxacin, moxifloxacin and susceptible to gentamicin, 
oxytetracycline, clindamycin, rifampicin, cotrimoxazole, fusidic 
acid, linezolid, fosfomycin, tigecycline and daptomycin. 
As shown in the US, CA-MRSA ST8 (“USA300”) may spread 
rapidly in MSM communities [3]. European doctors caring for HIV-
positive patients and MSM with skin and soft tissue infections 
should be aware of the possibility of CA-MRSA in order to provide 
proper care and prevent further spread. 
Targeted measures include proper bacteriological diagnosis of 
skin and soft tissue infections in patients attending dermatological 
and surgical practises, as well as in HIV-positive patients. When 
MRSA is detected, it is likely that the infection is caused by a 
CA-MRSA strain. Early recognition of CA-MRSA ST8 (“USA300”) 
is possible by PCR detection of the lukS-lukF and arcA genes 
[11]. Confirmation is obtained by additional typing such as spa-
typing, MLST, and SCCmec [7]. Further spread can be prevented 
by personal, environmental and health care hygienic measures 
[12,13].
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